Day One Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bender Jeremy
May 3 18:52 ET
Day One Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer York Charles N II
May 3 18:47 ET
Day One Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Blackman Samuel C.
Apr 22 18:42 ET
Day One Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Blackman Samuel C.
Mar 26 18:10 ET
Day One Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Blackman Samuel C.
Mar 13 16:30 ET
Day One Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Blackman Samuel C.
Feb 28 19:59 ET
Day One Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Dubow Adam
Feb 20 18:50 ET
Day One Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer York Charles N II
Feb 20 18:39 ET
Day One Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Blackman Samuel C.
Feb 20 18:29 ET
Day One Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bender Jeremy
Feb 20 18:19 ET
Day One Biopharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(9.0%),Peter Kolchinsky(9.0%), etc.
Feb 14 17:30 ET
Day One Biopharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-The Vanguard Group(5.48%)
Feb 13 17:14 ET
Day One Biopharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Atlas Venture Fund XI, L.P.(6.9%),Atlas Venture Associates XI, L.P.(6.9%), etc.
Feb 9 16:16 ET
Day One Biopharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(4.558%),Abigail P. Johnson(4.558%)
Feb 9 08:55 ET
Day One Biopharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.9%)
Jan 29 17:34 ET
Day One Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Grossman William
Jan 19 00:00 ET
Day One Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dable Habib J
Jan 19 00:00 ET
Day One Biopharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Grossman William
Jan 19 00:00 ET
Day One Biopharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Dable Habib J
Jan 19 00:00 ET
Day One Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer York Charles N II
Jan 9 00:00 ET
No Data
No Data